Pages without language links

From QIBA Wiki
Jump to: navigation, search

The following pages do not link to other language versions.

Prefix  

Showing below up to 100 results in range #1 to #100.

View (previous 100 | next 100) (20 | 50 | 100 | 250 | 500)

  1. 2009 Profile Template Sketch
  2. 2012 Call Summaries
  3. 2013 Call Summaries
  4. 2014 Call Summaries
  5. 2015 Call Summaries
  6. 2016 Call Summaries
  7. 2019
  8. 2020
  9. 2021
  10. AIUM/QIBA Pulse-Echo Quantitative Ultrasound Biomarker Ctte
  11. AIUM/QIBA Ultrasound Volume Blood Flow Biomarker Ctte
  12. ARCHIVE
  13. ASFNR Materials - Abstract for Review
  14. Acquisition Protocols Technical Subcommittee
  15. Additional letters of support can be found here
  16. Agenda from 02.17.2012 FDG-PET Tech Committee Call
  17. Alzheimer's Disease PET Archive
  18. Ambition Levels for Collaboration
  19. Archive
  20. Archive - Initial Target Selection and Roadmap
  21. Archive - Lung Density
  22. Archive for Lung Nodule Assessment in CT Screening Draft Profiles
  23. Archive for previously known QIBA Modality Committees
  24. Archived: 2009 COPD/Asthma Call Summaries
  25. Archived: 2010 - 2011 fMRI Reproducibility Call Summaries
  26. Archived: 2010 COPD/Asthma Call Summaries
  27. Archived: 2011 COPD/Asthma Call Summaries
  28. Archived: 2011 CT Volumetry - Group 3A Call Summaries
  29. Archived: 2012 CT Volumetry - Group 3A Call Summaries
  30. Archived: 2012 QIBA US SWS Technical Committee call summaries
  31. Archived: 2012 fMRI Reproducibility Call Summaries
  32. Archived: 2013 fMRI Bias WG Call Summaries
  33. Archived: 2014 fMRI Bias WG Call Summaries
  34. Archived: 2016 Lung Density BC Call Summaries
  35. Archived: fMRI Bias WG Call Summaries
  36. Archived: fMRI Reproducibility Call Summaries
  37. Archived "What is a Profile?" description as of 08.19.2011
  38. Archived - 2010-2011 fMRI Reproducibility Call Summaries
  39. Archived - 2011 fMRI Reproducibility Call Summaries
  40. Archived DCE-MRI Profiles
  41. Archived Versions
  42. Archived Versions of QIBA Vol CT - Group 3A draft documents
  43. Assessment Procedure Guidance
  44. Atherosclerosis Biomarkers Profile Draft Archive
  45. Balloting Process
  46. Bobby test
  47. CEUS BC Call Summaries
  48. CEUS Task Force (TF) Call Summaries
  49. COPD Group Call Summaries
  50. CTV-AD Considerations for Future Editions
  51. CT Acquisition Protocol Groundwork
  52. CT Angiography Biomarker Ctte
  53. CT Angiography Call Summaries Archive
  54. CT Angiography Profile Draft Archive
  55. CT Coordinating Committee
  56. CT Draft Proffered Protocols
  57. CT Small Lung Nodule Biomarker Ctte
  58. CT Volumetry BC Call Summaries Archive
  59. CT Volumetry Biomarker Ctte
  60. Call Agenda Topics
  61. Call Summaries
  62. Call Summaries Archive
  63. Catalog
  64. Change Tracking and File Naming
  65. Claim Confirmation Process
  66. Claim Guidance
  67. Claim Language/Detail
  68. Clinical Applications and Biological Targets Subcommittee
  69. Clinical Sites
  70. Clinical Trial Planning
  71. Clinical Trials Collaboration
  72. Columbia University Medical Center
  73. Combined: System Dependencies & Phantom Development Subcommittees
  74. Combined Nuclear Medicine Biomarker Committee Call Summaries
  75. Comment Resolutions
  76. Committee Organization
  77. Committee Procedures
  78. Committee Sunset Process
  79. Committee Template
  80. Committee on Image Archives
  81. Committee on Open Image Archives
  82. Committees
  83. Communications Committee
  84. Conformity Assessment
  85. Consensus Process
  86. Consensus Protocols
  87. CoreLab Partners, Inc.
  88. CoreLab Partners, Inc., Round-2
  89. Covariates Rationale
  90. DCE-MRI BC Call Summaries Archive
  91. DCE-MRI Project Page
  92. DCE MRI Biomarker Ctte
  93. DSC-MRI Call Summaries Archive
  94. DSC MRI Biomarker Ctte
  95. DTI MRI Biomarker Ctte
  96. DWI Literature Review
  97. DWI MR BC Call Summaries Archive
  98. DWI MR Biomarker Ctte
  99. DWI Profile Development Archive
  100. DWI Profile Draft Archive

View (previous 100 | next 100) (20 | 50 | 100 | 250 | 500)